3Keiko Furukawa,Yoshinori Ito,Shunji Takahashi,Masataka Sawaki,Nobuyuki Mizunuma,Noboru Horikoshi,Fujio Kasumi,Futoshi Akiyama,Goi Sakamoto,Kiyonori Furukawa,Takashi Tajiri,Kiyohiko Hatake.Efficacy and safety of combined trastuzumab and paclitaxel therapy as a second-line treatment in women with metastatic Breast Cancer: A single institutional experience[J].Breast Cancer.2006(4)
4Wen XF,Yang G,Mao W,et al.HER-2 signaling modu-lates the equilibrium between pro-and antiangiogenicfactors via distinct pathways:implications for HER-2-targeted antibody therapy[].Oncegene.2006
5Arnould L,GellyM,Penault-Llorca F,et al.Trastuzum-ab-based treatment ofHER-2-positive breast cancer:an antibody-dependent cellular cytotoxicity mecha-nism[].British Journal of Cancer.2006
6Furukawa K,Ito Y,Takahashi S,et al.Efficacy andsafety of combined trastuzumab and Paclitaxel ther-apy as a second-line treatment in women with meta-static breast cancer:a single institutional experience[].Breast Cancer.2006
7Ciardiello F,Troiani T,Caputo F,et al.Phase II studyof gefitinib in combination with docetaxel as first-linetherapy in metastatic breast cancer[].British Journal of Cancer.2006
8Karen E,Lackey KE.Lessons from the drug discov-ery of lapatinib,a dual ErbB1/2 tyrosine kinase inhibi-tor[].Current Topics in Medicinal Chemistry.2006
9Wood ER,Truesdale AT,McDonald OB,et al.A uniquestructure for epidermal growth receptor bound toGW572016(lapatinib):Relationships among proteinconformation,inhibitor off-rate,and receptor activityin tumor cells[].Cancer Research.2004
10Blackwell KL,Kaplan EH,Franco SX,et al.A phase II,open-label,multicenter study of GW572016 in pa-tients with trastuzumab-refractory metastatic breastcancer[].Proceedings of the American Society of Clinical Oncology.2004
9Li H, Gong J, Jiang X, et al. arsenic trioxide treatment of rabbit liver vx-2 carcinoma via hepatic arterial cannulation-induced apoptosis and decreased levels of survivin in the tumor tissue[ J]. Croat Med J,2013,54 (1) :12-16.
10Ferreira D M, Afonso M B, Rodrigues P M, et al. c- Jun N-terminal kinase 1/c-Jun activation of the p53/ microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver [ J ]. Mol Cell Biol,2014,34(6) :1100-1120.
